Načítá se...
Janus kinase antagonists and other novel small molecules for the treatment of Crohn’s disease
There is an ongoing unmet need for effective therapies for Crohn’s disease (CD). Treatments for Crohn’s disease continue to evolve from the traditional biologics to novel small molecules with targeted mechanisms directed towards pathways that are dysregulated in Crohn’s disease. There are multiple e...
Uloženo v:
| Vydáno v: | Gastroenterol Clin North Am |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5643010/ https://ncbi.nlm.nih.gov/pubmed/28838419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gtc.2017.05.015 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|